Literature DB >> 15322174

Functional and genetic analysis of two CD8 T cell subsets defined by the level of CD45RC expression in the rat.

Emmanuel Xystrakis1, Pierre Cavailles, Anne S Dejean, Bastien Cautain, Céline Colacios, Dominique Lagrange, Marie-Jose van de Gaar, Isabelle Bernard, Daniel Gonzalez-Dunia, Jan Damoiseaux, Gilbert J Fournié, Abdelhadi Saoudi.   

Abstract

Differential cytokine production by T cells plays an important role in the outcome of the immune response. We show that the level of CD45RC expression differentiates rat CD8 T cells in two subpopulations, CD45RC(high) and CD45RC(low), that have different cytokine profiles and functions. Upon in vitro stimulation, in an Ag-presenting cell-independent system, CD45RC(high) CD8 T cells produce IL-2 and IFN-gamma while CD45RC(low) CD8 T cells produce IL-4, IL-10, and IL-13. In vitro, these subsets also exhibit different cytotoxic and suppressive functions. The CD45RC(high)/CD45RC(low) CD8 T cell ratio was determined in Lewis (LEW) and Brown-Norway (BN) rats. These two rat strains differ with respect to the Th1/Th2 polarization of their immune responses and to their susceptibility to develop distinct immune diseases. The CD45RC(high)/CD45RC(low) CD8 T cell ratio is higher in LEW than in BN rats, and this difference is dependent on hemopoietic cells. Linkage analysis in a F(2)(LEW x BN) intercross identified two quantitative trait loci on chromosomes 9 and 20 controlling the CD45RC(high)/CD45RC(low) CD8 T cell ratio. This genetic control was confirmed in congenic rats. The region on chromosome 9 was narrowed down to a 1.2-cM interval that was found to also control the IgE response in a model of Th2-mediated disorder. Identification of genes that control the CD45RC(high)/CD45RC(low) CD8 T cell subsets in these regions could be of great interest for the understanding of the pathophysiology of immune-mediated diseases.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15322174     DOI: 10.4049/jimmunol.173.5.3140

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  Genetic regulation of T regulatory, CD4, and CD8 cell numbers by the arthritis severity loci Cia5a, Cia5d, and the MHC/Cia1 in the rat.

Authors:  Max Brenner; Teresina Laragione; Nuriza C Yarlett; Pércio S Gulko
Journal:  Mol Med       Date:  2007 May-Jun       Impact factor: 6.354

2.  Sex and age as determinants of rat T-cell phenotypic characteristics: influence of peripubertal gonadectomy.

Authors:  Nevena Arsenović-Ranin; Duško Kosec; Ivan Pilipović; Mirjana Nacka-Aleksić; Biljana Bufan; Zorica Stojić-Vukanić; Gordana Leposavić
Journal:  Mol Cell Biochem       Date:  2017-03-09       Impact factor: 3.396

3.  Unusual case presentations associated with the CD45 C77G polymorphism.

Authors:  E Z Tchilian; J Gil; M L Navarro; E Fernandez-Cruz; H Chapel; S Misbah; B Ferry; H Renz; R Schwinzer; P C L Beverley
Journal:  Clin Exp Immunol       Date:  2006-12       Impact factor: 4.330

4.  Ovarian hormone level alterations during rat post-reproductive life-span influence CD8 + T-cell homeostasis.

Authors:  Nevena Arsenović-Ranin; Duško Kosec; Mirjana Nacka-Aleksić; Ivan Pilipović; Zorica Stojić-Vukanić; Jasmina Djikić; Biljana Bufan; Gordana Leposavić
Journal:  Exp Biol Med (Maywood)       Date:  2015-02-24

Review 5.  Neuroinflammation: Extinguishing a blaze of T cells.

Authors:  Nail Benallegue; Hania Kebir; Jorge I Alvarez
Journal:  Immunol Rev       Date:  2022-07-31       Impact factor: 10.983

6.  Combinations of CD45 isoforms are crucial for immune function and disease.

Authors:  Ritu Dawes; Svetla Petrova; Zhe Liu; David Wraith; Peter C L Beverley; Elma Z Tchilian
Journal:  J Immunol       Date:  2006-03-15       Impact factor: 5.422

7.  Transient antibody targeting of CD45RC inhibits the development of graft-versus-host disease.

Authors:  Laetitia Boucault; Maria-Dolores Lopez Robles; Allan Thiolat; Séverine Bézie; Michael Schmueck-Henneresse; Cécile Braudeau; Nadège Vimond; Antoine Freuchet; Elodie Autrusseau; Frédéric Charlotte; Rabah Redjoul; Florence Beckerich; Mathieu Leclerc; Eliane Piaggio; Regis Josien; Hans-Dieter Volk; Sébastien Maury; José L Cohen; Ignacio Anegon; Carole Guillonneau
Journal:  Blood Adv       Date:  2020-06-09

8.  Ex Vivo Expanded Human Non-Cytotoxic CD8+CD45RClow/- Tregs Efficiently Delay Skin Graft Rejection and GVHD in Humanized Mice.

Authors:  Séverine Bézie; Dimitri Meistermann; Laetitia Boucault; Stéphanie Kilens; Johanna Zoppi; Elodie Autrusseau; Audrey Donnart; Véronique Nerrière-Daguin; Frédérique Bellier-Waast; Eric Charpentier; Franck Duteille; Laurent David; Ignacio Anegon; Carole Guillonneau
Journal:  Front Immunol       Date:  2018-01-31       Impact factor: 7.561

9.  CD45RC isoform expression identifies functionally distinct T cell subsets differentially distributed between healthy individuals and AAV patients.

Authors:  Laurence Ordonez; Isabelle Bernard; Fatima-Ezzahra L'faqihi-Olive; Jan Willem Cohen Tervaert; Jan Damoiseaux; Abdelhadi Saoudi
Journal:  PLoS One       Date:  2009-04-21       Impact factor: 3.240

10.  A higher risk of acute rejection of human kidney allografts can be predicted from the level of CD45RC expressed by the recipients' CD8 T cells.

Authors:  Laurence Ordonez; Isabelle Bernard; Marianne Chabod; Jean-François Augusto; Valerie Lauwers-Cances; Christelle Cristini; Maria-Cristina Cuturi; Jean-François Subra; Abdelhadi Saoudi
Journal:  PLoS One       Date:  2013-07-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.